Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Clarivate Plc Ordinary Shares (NY:CLVT)

3.395 -0.265 (-7.24%)
Streaming Delayed Price Updated: 2:46 PM EDT, Apr 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Clarivate Plc Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >
12 Industrials Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Clarivate Partners With Libraries To Unveil AI Research Assistant, Boosting Academic Integrity And Discovery
Clarivate launched Primo Research Assistant, which is a new generative AI-powered library discovery solution. Primo Research Assistant, part of the Primo Discovery solution, uses a Retrieval Augmented... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
CLVT Stock Earnings: Clarivate Beats EPS, Misses Revenue for Q2 2024
CLVT stock results show that Clarivate beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Critical Insights From Clarivate Analyst Ratings: What You Need To Know
Via Benzinga
The Analyst Landscape: 5 Takes On Clarivate
Via Benzinga
Earnings Scheduled For February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million. 
Via Benzinga
Earnings Scheduled For February 19, 2025
Via Benzinga
Bargains Galore? 3 Stocks With Insider Buying in the Millions
Clarivate, Prospect Capital, and Nine Energy Service insiders bought millions in stock. See what’s driving this insider confidence. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
BridgeBio Pharma, Rigetti Computing, Bath & Body Works And Other Big Stocks Moving Higher On Monday
Via Benzinga
Israel, Lebanon Reach Reported Cease-Fire Deal: Gold, Oil Tumble; S&P 500, Dow Jointly Hit Record Highs
Israel and Lebanon agree on framework for cease-fire deal to end over a year of conflict, Axios reports. Global markets react with gold and oil prices falling. 
Via Benzinga
Topics Stocks
Exposures US Equities
Preview: Clarivate's Earnings
Via Benzinga
The Latest Analyst Ratings for Clarivate
Via Benzinga
Riot Platforms & North Face Parent V.F. Corp Are Among 11 Mid-Cap Stocks That Performed The Best Last Week (July 14-July 20): Are Others In Your Portfolio?
Top mid-cap stock performers: VIRT (+30%), VFC (+22%), NFE (+20%), RIOT (+16%), CLVT (+14%), AMN (+14%), BKU (+13%), MARA (+12%), EXPI (+12%), ZETA (+11%), NATL (+11%). 
Via Benzinga
Clarivate: The Cheapest AI Stock Worth Buying?
Clarivate is deeply undervalued relative to its earnings potential and is set up for a stock price reversal and rally the Q2 results could catalyze. 
Via MarketBeat
Topics Artificial Intelligence
Exposures Artificial Intelligence
Top 5 Stocks to Watch for AI-Driven Gains That Aren’t NVIDIA
These five business services stocks are expected to lead their industries and the market with AI-powered productivity gains and earnings leverage. 
Via MarketBeat
Why Is Clarivate Stock Trading Higher Premarket Monday?
Clarivate Plc launched AI-enhanced Trademark Watch Analyzer at 2024 International Trademark Association Annual Meeting, connecting users to trademark data in 258 countries and territories. Solution... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
CLVT Stock Earnings: Clarivate Meets EPS, Beats Revenue for Q1 2024
CLVT stock results show that Clarivate met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Analytics Firm Clarivate Acquires AI Start-Up MotionHall - What's On The Cards?
Clarivate has agreed to acquire the majority of assets of MotionHall, a Silicon Valley technology start-up. MotionHall serves life sciences with vertical artificial intelligence (AI) solutions. The... 
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Exor Amplifies Stake In Clarivate, Proposes New Board Member
Exor N.V. increases stake in Clarivate Plc to 10.1%, with potential to reach 17.5%. Suzanne Heywood to join board, showing strong support for Clarivate's growth and mission. 
Via Benzinga
S&P 500, Nasdaq 100 Dip, Small Caps Surge; Bitcoin Tops $57,000, 2 Biotech Stocks Skyrocket: What's Driving Markets Tuesday?
On Tuesday, large-cap indices experienced a downturn, while small caps surged, reflecting investor attention on stock valuations. 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Helix Energy Solutions Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings. 
Via Benzinga
12 Industrials Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Industrials Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Industrials Stocks Moving In Monday's After-Market Session
Via Benzinga
Clarivate Buys Alethea, Creates Academia And Government Innovation Incubator
Clarivate PLC (NYSE: CLVT) disclosed the plan to create an Academia and Government Innovation Incubator to  
Via Benzinga
Clarivate Launches AI-Powered Tool For IP Forecasts And Budgets
Clarivate Plc (NYSE: CLVT) has launched Forecast, the next-generation artificial intelligence (AI)-driven solution designed to enable intellectual property (IP) professionals to efficiently  
Via Benzinga
Topics Artificial Intelligence Intellectual Property
Exposures Artificial Intelligence Intellectual Property
Have Million-Dollar Gene Therapies Finally Reached An Inflection Point?
Gene therapies are clearing the FDA and reaching seriously ill patients. They could cost millions. 
Via Investor's Business Daily
Exposures Product Safety
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.